It's Official: Bemotrizinol Can Now Be Used in US Sunscreens
August 9, 2026 — the new filter's effective date is here.
Bemotrizinol (Parsol Shield) is approved in formulas up to 6% for adults and children 6 months and older.
Cosmetic chemists describe bemotrizinol as broad-spectrum and so photostable it retains the large majority of its activity after intense UV exposure.
Questions we get a lot
What is bemotrizinol (Parsol Shield)?
Bemotrizinol (trade name Parsol Shield; also known as Tinosorb S) is a broad-spectrum UVA+UVB filter that is highly photostable. On June 9, 2026 the FDA approved it — the first new sunscreen active added to the US monograph since the 1990s — for adults and children 6 months and older at up to 6%.
Can US sunscreens use bemotrizinol now?
Yes. With the FDA order in effect, manufacturers may legally formulate OTC sunscreens with bemotrizinol (Parsol Shield) at up to 6%. Reformulation, testing and supply take time, so expect products to reach US shelves gradually rather than all at once.
Are next-gen UV filters better than older ones?
Newer filters such as bemotrizinol generally give broader, more even UVA coverage and far better photostability than older ones like avobenzone, which degrades in sunlight. They also tend to feel more elegant — though applying enough and reapplying still matter most.
r/SkincareAddiction: 'Is bemotrizinol finally coming to US sunscreens?'